Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-19002

Single-particle
3.41 Å
EMD-19002
3D View Gallery
Deposition: 29/11/2023
Map released: 08/05/2024
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-19002
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8r8k summary report (pdf.gz) Map and 8r8k FULL report (pdf.gz)
EMICSS annotations (xml)

XBB-4 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein

EMD-19002

Single-particle
3.41 Å
EMD-19002
3D View Gallery
Deposition: 29/11/2023
Map released: 08/05/2024
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2, Tequatrovirus T4
Sample: XBB-4 Fab in complex with SARS-COV-2 BA.2.12.1 Spike Glycoprotein
Fitted models: 8r8k

Deposition Authors: Duyvesteyn HME , Ren J , Stuart DI
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.
Liu C, Zhou D , Dijokaite-Guraliuc A , Supasa P, Duyvesteyn HME , Ginn HM, Selvaraj M, Mentzer AJ , Das R, de Silva TI, Ritter TG, Plowright M, Newman TAH , Stafford L, Kronsteiner B, Temperton N , Lui Y, Fellermeyer M, Goulder P, Klenerman P, Dunachie SJ, Barton MI, Kutuzov MA, Dushek O, Fry EE, Mongkolsapaya J, Ren J , Stuart DI , Screaton GR
(2024) Cell Rep Med , 5 , 101553 - 101553
PUBMED: 38723626
DOI: doi:10.1016/j.xcrm.2024.101553
ISSN: 2666-3791